Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
30.43
-0.25 (-0.80%)
Nov 3, 2026, 2:04 PM EST - Market open

Pfizer Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Oct '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21
Net Income
-2472,687-1,6483,542-2,9674104,465413,115-3,369-2,3822,3275,5434,9948,6099,9057,8643,393
Depreciation & Amortization
1,6111,6101,6601,658-1,6141,7881,7471,7271,7321,6661,5551,5681,4691,5051,1761,1691,1781,324
Asset Writedown & Restructuring Costs
4,404354,433370-3483,1656572991402,913177622882772363340194
Loss (Gain) From Sale of Investments
-1,870------------------
Stock-Based Compensation
249272225201-17017727420622012115114810536413528786496
Other Operating Activities
-1,478-270-912-1,082--845-1,738-1,292-526-786-4,5675,164-1,397-685-998402-444-1,906-1,414
Change in Accounts Receivable
---263----109---347---261----3,811
Change in Inventory
--561----854----1,169----591----1,125
Change in Accounts Payable
---469----1,023----300---1,191---1,242
Change in Other Net Operating Assets
-1,816-1,7321,761-36--1,9194,912879-3,535-3,3369,572-1,199-3,916-5,5071,581-4,585-2,766-7305,631
Operating Cash Flow
8352,6155,3484,603-2,3356,7216,714-1,7811,0905,2403,456-1,2081,2128,5825,9748,1706,5415,914
Operating Cash Flow Growth (YoY)
-11.99%-20.43%-31.44%-114.22%28.26%94.27%--10.07%-38.94%-42.15%--81.47%45.11%-44.83%-27.69%44.14%5.14%

Investing Activities

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Oct '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21
Capital Expenditures
-533-436-845-602--564-917-651-637-704-1,044-810-914-1,139-1,001-841-751-643-1,002
Cash Acquisitions
---6,927--------43,405--25--16,772---6,225-
Investment in Securities
2,6401,1991,763-1,840-3,539-718-1,4125,2562,43533,4381,350-24,0224,47313,354-3,635-10,4857,448-1,645
Other Investing Activities
-122-13712-299126-19115348-524-1993,849-77-1361
Investing Cash Flow
2,106785-6,146-2,430-3,274-1,623-2,0574,6001,732-10,996888-25,4853,315-4,410-627-11,313567-2,586

Financing Activities

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Oct '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21
Short-Term Debt Issued
---------1,444---237-----
Total Debt Issued
--5,991---7322,1614,5701,4447,672-2230,630237-8663664,391--265
Short-Term Debt Repaid
--127----2,434----2,367--------220-
Long-Term Debt Repaid
----------1,250----269----1,609-
Total Debt Repaid
-1,186-127-2,9066--2,434-3,452-4,411-4,586-3,617103-1,406-1,000-269-1,911-3,887220-1,829-1,098
Net Debt Issued (Repaid)
-1,186-1273,0856--2,434-2,720-2,250-16-2,1737,775-1,42829,630-32-2,777-3,5214,611-1,829-1,363
Repurchase of Common Stock
------------------2,000-
Common Dividends Paid
-2,451-2,445-2,445-2,444--2,437-2,380-2,380-2,380-2,372-2,315-2,314-2,315-2,303-2,245-2,245-2,244-2,249-2,189
Dividends Paid
-2,451-2,445-2,445-2,444--2,437-2,380-2,380-2,380-2,372-2,315-2,314-2,315-2,303-2,245-2,245-2,244-2,249-2,189
Other Financing Activities
-26-284-44-39--356-14-6-63-386-18-37-141-43675153-500201
Financing Cash Flow
-3,663-2,856596-2,477--5,227-5,114-4,636-2,459-4,9315,442-3,77927,174-2,771-5,015-5,7612,520-6,578-3,351

Net Cash Flow

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Oct '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21
Foreign Exchange Rate Adjustments
-41952--7-299-18-28-1-32-5-2-26-72-66-1-27
Miscellaneous Cash Flow Adjustments
---2--1--11--2-1--1-1--
Net Cash Flow
-726563-197-300-374-4529343-2,137-3155354751,754-870-486-688529-50

Free Cash Flow

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Oct '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21
Free Cash Flow
3022,1794,5034,001-1,7715,8046,063-2,4183864,1962,646-2,122737,5815,1337,4195,8984,912
Free Cash Flow Growth (YoY)
-23.04%-22.42%-34.01%-358.81%38.32%129.14%-428.77%-44.65%-48.45%--98.76%54.34%-49.73%-31.06%48.04%2.08%
Free Cash Flow Margin
2.01%15.08%25.65%24.02%-12.91%32.67%34.25%-18.20%2.59%28.80%19.61%-16.31%0.40%31.21%22.67%26.74%22.98%20.61%
Free Cash Flow Per Share
0.050.380.790.70-0.311.021.06-0.420.070.740.47-0.370.011.320.901.301.020.85
Levered Free Cash Flow
2,849418.137,0601,706-1,4727,4353,3521,817-800.511,171-4,5121,896-3,2418,6095,2207,0753,6326,240
Unlevered Free Cash Flow
3,265835.637,5052,114-1,8807,8973,8422,303-306.7511,601-4,0772,214-3,0428,8055,4157,2583,8336,438

Additional Metrics

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Oct '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21
Cash Interest Paid
1,248293981275-3531,3942801,1384151,062332402419321350318453262
Cash Income Tax Paid
3,467721,017178-1524334862,5021842408821,6963292,9481,8212,7443544,484
Change in Working Capital
-1,816-1,7321,590-36--1,9192,926879-3,535-3,3368,450-1,199-3,916-5,5072,442-4,585-2,766-7301,937
SEC Filings: 10-K · 10-Q